Zachary Laksman

Academic Appointment

Assistant Professor

Research Focus

Blood, Heart and Circulation

Contact Info

zlaksman@mail.ubc.ca

Biography

Dr. Zachary Laksman is a member of the Centre for Cardiovascular Innovation, the director of the St. Paul’s Hospital Atrial Fibrillation Clinic and the director of the St. Paul’s Hospital Inherited Arrhythmia Clinic. He is also an assistant professor in the Department of Medicine and the School of Biomedical Engineering.

Dr. Laksman specializes in the management of cardiac arrhythmias, simple and complex ablation and device implantation. He is a clinician-scientist with a specific focus on cardiogenetics, stem cell disease modeling and personalized medicine. Dr. Laksman’s research is funded by the Stem Cell Network, the Canadian Institutes of Health and Research, the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Publications

The Canadian journal of cardiology -
Return of Results Policies for Genomic Research: Current Practices & The Hearts in Rhythm Organization Approach.
Comber DA, Davies B, Roberts JD, Tadros R, Green MS, Healey JS, Simpson CS, Sanatani S, Steinberg C, MacIntyre C, Angaran P, Duff H, Hamilton R, Arbour L, Leather R, Seifer C, Fournier A, Atallah J, Kimber S, Makanjee B, Alqarawi W, Cadrin-Tourigny J, Joza J, Gibbs K, Robb L, Zahavich L, Gardner M, Talajic M, Virani A, Krahn AD, Lehman A, Laksman ZWM
Pacing and clinical electrophysiology : PACE -
The clinical utility of procainamide-induced late potentials on the signal averaged ECG.
Pearman CM, Walia J, Alqarawi W, Larsen JM, Leach E, Krahn AD, Laksman Z
Current protocols -
Applying Machine Learning to Stem Cell Culture and Differentiation.
Ashraf M, Khalilitousi M, Laksman Z
Circulation. Genomic and precision medicine -
Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories.
Davies B, Bartels K, Hathaway J, Xu F, Roberts JD, Tadros R, Green MS, Healey JS, Simpson CS, Sanatani S, Steinberg C, Gardner M, Angaran P, Talajic M, Hamilton R, Arbour L, Seifer C, Fournier A, Joza J, Krahn AD, Lehman A, Laksman ZWM
Stem cell reports -
Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes.
Shafaattalab S, Lin E, Christidi E, Huang H, Nartiss Y, Garcia A, Lee J, Protze S, Keller G, Brunham L, Tibbits GF, Laksman Z

Zachary Laksman

Biography

Publications

Return of Results Policies for Genomic Research: Current Practices & The Hearts in Rhythm Organization Approach.

The clinical utility of procainamide-induced late potentials on the signal averaged ECG.

Applying Machine Learning to Stem Cell Culture and Differentiation.

Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories.

Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes.

Are you a researcher?